Sacituzumab govitecan shows promise in treating the most aggressive type of breast cancer

ADC linker

Sacituzumab govitecan shows promise in treating the most aggressive type of breast cancer

2021-11-24 // 0 Comments

Watertown, MA, 2021-Nov-24 — /EPR Network/ — A unique antibody drug conjugate (ADC), which delivers a high dose of a cancer-killing drug to tumor cells [read full press release…]

ADCs Effectively Targets Surface Protein Of Neuroblastoma In Children–Biochempeg

2020-09-29 // 0 Comments

Watertown, MA, 2020-Sep-29 — /EPR Network/ — Physician-scientists in the Cancer Center at Children’s Hospital of Philadelphia (CHOP) have developed a preclinical, potent therapy attached [read full press release…]